Skip to main content
Fig. 1 | Research Involvement and Engagement

Fig. 1

From: Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials

Fig. 1

The Excelerator Framework. Our team developed a novel framework, involving five component studies (plus sharing of the Patient Partner Diagnosis & Treatment Experience), to evidence-inform an early phase clinical trial. Through application of our framework and use of an integrated knowledge translation approach we aim to accelerate the translation of CAR-T cell therapy to the clinic

Back to article page
\